Risk assessment report of potential impurities in cetirizine dihydrochloride-Reference-Cited by-同舟云学术

Risk assessment report of potential impurities in cetirizine dihydrochloride

Published:2020-09 Issue: Volume:189 Page:113425
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Leistner Adrian,Haerling Stephan,Kreher Joerg-Detlef,Becker Ivonne,Jung Dirk,Holzgrabe Ulrike

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference24 articles.

1. Sartan Medicines: Companies to Review Manufacturing Processes to Avoid Presence of Nitrosamine Impurities, EMA/248364/2019 Rev 1;European Medicines Agency,2019

2. Laboratory Tests | Ranitidine;U.S. Food and Drug Administration,2019

3. EMA Update on Metformin Diabetes Medicines, EMA/660975/2019;European Medicines Agency,2019

4. Information on Nitrosamines for Marketing Authorisation Holders, EMA/189634/2019;European Medicines Agency,2019

5. WHO Colloboration Center for Drug Statistics Methodology,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of advanced high resolution mass spectrometric techniques for the analysis of losartan potassium regarding known and unknown impurities;Journal of Pharmaceutical and Biomedical Analysis;2024-03

2. The quality of drugs and drug products – Always guaranteed?;Journal of Pharmaceutical and Biomedical Analysis;2024-02

3. Development of a sensitive LC-MS/MS method for determination of N-nitrosopiperazine in levocetirizine;Analytical Methods;2024

4. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry;Journal of Chromatography A;2023-10

5. Advances of hyphenated technique in impurity profiling of active pharmaceutical ingredients and pharmaceutical products;SEPARATION SCIENCE PLUS;2023-08-15